Previous 10 | Next 10 |
Summary Medical device companies, particularly those focused on robotics, have been clobbered this year while the Health Care sector outperforms. Post-Covid, Intuitive Surgical could rebound for a few reasons. With a still-high valuation, fundamental investors might still be c...
Summary Pharmaceuticals and biotechnology have the best value and quality scores. Healthcare providers look undervalued relative to 11-year averages. Other healthcare industries don’t look attractive. Focus on a biotech ETF: GNOM (and why I don’t like it). ...
Summary The Health Care sector and Biotech niche have both been interesting sources of relative market strength in recent months; one defensive, one more risk-on. 10x Genomics was a massive winner around the Covid-19 pandemic, but an improving health situation around the world pos...
Summary Sector ETFs performance last week through Friday’s close wasn’t fully lost as many sectors managed to hold onto their gains from earlier in the week. Compared to the S&P 500’s modest gains on the week, Energy’s outperformance has little prec...
Summary The summer rally was supported with the temporary Fed dovishness. The expected year-end rally might not have that support. Thus, tactically, I am neutral for now. The tactical buy opportunity I was short S&P 500 (SPY) earlier this year, but decide...
Summary Seasonal trends and the mid-term elections can prove to be a catalyst for the next short-term move in stocks. The Global bear market has signaled the oncoming global economic slowdown, and the economic data is confirming that. Corporate Earnings season is here and that...
Summary XLV's technicals demonstrate the ETF will be trading in a range for a while. High implied volatility and put skew bring opportunity to put sellers. The sale of an out-of-the-money put combined with an out-of-the-money call spread is a high probability of profit setup i...
Summary We expect macro headwinds will continue to pressure U.S. corporate earnings in the coming months. We expect earnings expectations to decline as multinational firms realize foreign exchange headwinds that accelerated over the past year. Investors can avoid undue interna...
Summary Significant drops in price this year have erased years of built-up gains, and now a lot of areas of global financial markets are looking at double-digit percentage declines going back to the late 2010s. The major US index ETFs are sitting on 20%+ declines in 2022, but they...
Summary The Health Care sector has been a source of relative safety during this tumultuous September. While some large-caps in the space are catching bids, one smaller health care services and facilities company is sharply lower in 2022. Earnings are expected to improve, but t...
News, Short Squeeze, Breakout and More Instantly...
SPDR Select Sector Fund - Health Care Company Name:
XLV Stock Symbol:
NYSE Market:
2024-07-09 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-29 11:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...